Ekso Bionics Holdings Stock News

Ekso Bionics Holdings Inc (EKSO) shares closed 1.6% lower than its previous 52 week low, giving the company a market cap of $33M. The stock is currently up 0.8% year-to-date, down 61.4% over the past 12 months, and down 95.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 68.8% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -111.9% The company's stock price performance over the past 12 months lags the peer average by 394.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Ekso Bionics <> estimates record Q4 revenues in the range of $3.9 million to $4.1 million vs

RICHMOND, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that mana

Ekso Bionics Holdings Inc (EKSO) shares closed 4.6% lower than its previous 52 week low, giving the company a market cap of $35M. The stock is currently down 53.8% year-to-date, down 59.5% over the past 12 months, and down 95.4% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 97.8% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -646.8% The company's stock price performance over the past 12 months lags the peer average by -800.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

RICHMOND, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today

- Foundation Donates Units to Two Inpatient Rehabilitation Facilities in Nebraska -

- Foundation Donates Units to Two Inpatient Rehabilitation Facilities in Nebraska -

State Street Corp purchased a new position in shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 13,780 shares of the companys stock, valued at approximately $76,000. Other institutional investors have also recently added to or reduced []

According to the new market research report "Medical Exoskeleton Market by Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper and Full Body) & Mobility (Mobile, Stationary) - Global Forecasts to 2026", published by

DUBLIN, Dec. 2, 2021 /PRNewswire/ -- The "Global Robotic Exoskeletons Market Trends and Opportunities Report 2021" report has been added to ResearchAndMarkets.com''s offering. The need for robotic exoskeletons is driven by the need to eliminate worker injuries, to help disabled individuals…

The Medical robots assist with surgery, streamline hospital logistics, and enable providers to give more direct attention to patients. Robots in the medical field are transforming how surgeries are performed, streamlining supply delivery and disinfection, and freeing up time for

The world class Medical Exoskeleton Market report studies extensive evaluation of the market growth predictions and restrictions. The strategies range from new product launches, expansions, agreements, joint ventures, partnerships, to acquisitions. This report comprises of a deep knowledge and information

In the superior Neurorehabilitation Devices market report, the whole and crystal clear outline of the Neurorehabilitation Devices market is penned down which is valuable for many businesses. The info covered in this consistent report helps businesses know how patents, licensing

A new market study is released on Global "Neurorehabilitation Gaming Systems Market 2021" with data Tables for historical and forecast years represented with Chats & Graphs with easy to understand detailed analysis. The report also sheds light on present scenario